These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3251783)

  • 21. Synthesis and pharmacological evaluation of novel beta-nitrostyrene derivatives as tyrosine kinase inhibitors with potent antiplatelet activity.
    Wang WY; Hsieh PW; Wu YC; Wu CC
    Biochem Pharmacol; 2007 Aug; 74(4):601-11. PubMed ID: 17601492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 3,5-Diphenyl-1H-pyrazole derivatives. VII--Esters, 2-dialkylaminoethyl ethers and N-substituted carbamates of 1-(2-hydroxy-3-phenoxypropyl)-3,5-diphenyl-1H-pyrazole with depressant and platelet antiaggregating activities.
    Bruno O; Bondavalli F; Ranise A; Schenone P; Losasso C; Cenicola ML; Stella L; Donnoli D; Marmo E
    Farmaco; 1990 May; 45(5):527-43. PubMed ID: 2222724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental study on anticoagulant and antiplatelet aggregation activity of a chemically sulfated marine polysaccharide YCP.
    Han F; Yao W; Yang X; Liu X; Gao X
    Int J Biol Macromol; 2005 Sep; 36(4):201-7. PubMed ID: 16102810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, Anticlotting and Antiplatelet Effects of 1,2,3-Triazoles Derivatives.
    Moura LA; de Almeida AC; da Silva AV; de Souza VR; Ferreira VF; Menezes MV; Kaiser CR; Ferreira SB; Fuly AL
    Med Chem; 2016; 12(8):733-741. PubMed ID: 27140186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and anti-platelet evaluation of 2-benzoylaminobenzoate analogs.
    Hsieh PW; Chiang SZ; Wu CC; Lo YC; Shih YT; Wu YC
    Bioorg Med Chem; 2008 May; 16(10):5803-14. PubMed ID: 18407506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-substituted 4-carboxy-1-phenyl-1H-pyrazole-5-propanamides with antiinflammatory, analgesic, antipyretic and platelet antiaggregating activities.
    Menozzi G; Mosti L; Schenone P; D'Amico M; Falzarano C; Rossi F
    Farmaco; 1993 Apr; 48(4):539-49. PubMed ID: 8357469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Indapamide inhibits human platelet aggregation in vitro: comparison with hydrochlorothiazide.
    Rendu F; Bachelot C; Molle D; Caen J; Guez D
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S57-63. PubMed ID: 7508063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel thrombin inhibitors with azaphenylalanine scaffold.
    Zega A; Trampus-Bakija A; Fortuna M; Stegnar M; Tschopp TB; Steiner B; Urleb U
    Pharmazie; 2001 Sep; 56(9):683-5. PubMed ID: 11593985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pyrazolidine derivatives: a comparative study of their effects on platelet aggregation.
    Cepelák V; Cepeláková H; Brůnová B; Kuchar M; Roubal Z
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):839-48. PubMed ID: 94876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New pyrimido[5,4-c]cinnolines with antiplatelet activities.
    Rehse K; Gonska H
    Arch Pharm (Weinheim); 2005 Dec; 338(12):590-7. PubMed ID: 16281308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pyran derivatives XIX. (Dialkylamino) substituted 1-benzopyranones and naphthopyranones with platelet antiaggregating activity.
    Di Braccio M; Roma G; Leoncini G; Poggi M
    Farmaco; 1995 Oct; 50(10):703-11. PubMed ID: 8590578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of SR121566A, a potent GP IIb-IIIa antagonist on platelet-mediated thrombin generation in vitro and in vivo.
    Herault JP; Peyrou V; Savi P; Bernat A; Herbert JM
    Thromb Haemost; 1998 Feb; 79(2):383-8. PubMed ID: 9493595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiplatelet and antithrombotic activities of CP201, a newly synthesized 1,4-naphthoquinone derivative.
    Jin YR; Hwang KA; Cho MR; Kim SY; Kim JH; Ryu CK; Son DJ; Park YH; Yun YP
    Vascul Pharmacol; 2004 Feb; 41(1):35-41. PubMed ID: 15135330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis, and inhibition of platelet aggregation for some 1-o-chlorophenyl-1,2,3,4-tetrahydroisoquinoline derivatives.
    Yang J; Hua WY; Wang FX; Wang ZY; Wang X
    Bioorg Med Chem; 2004 Dec; 12(24):6547-57. PubMed ID: 15556771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of baicalein derivatives as potential anti-aggregatory and anti-inflammatory agents.
    Huang WH; Lee AR; Chien PY; Chou TC
    J Pharm Pharmacol; 2005 Feb; 57(2):219-25. PubMed ID: 15720786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and antibacterial activity of a novel series of potent DNA gyrase inhibitors. Pyrazole derivatives.
    Tanitame A; Oyamada Y; Ofuji K; Fujimoto M; Iwai N; Hiyama Y; Suzuki K; Ito H; Terauchi H; Kawasaki M; Nagai K; Wachi M; Yamagishi J
    J Med Chem; 2004 Jul; 47(14):3693-6. PubMed ID: 15214796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and in vitro inhibitory activity on human platelet aggregation of novel properly substituted 4-(1-piperazinyl)coumarins.
    Di Braccio M; Grossi G; Roma G; Grazia Signorello M; Leoncini G
    Eur J Med Chem; 2004 May; 39(5):397-409. PubMed ID: 15110966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and SAR of heteroaryl-phenyl-substituted pyrazole derivatives as highly selective and potent canine COX-2 inhibitors.
    Cheng H; Lundy DeMello KM; Li J; Sakya SM; Ando K; Kawamura K; Kato T; Rafka RJ; Jaynes BH; Ziegler CB; Stevens R; Lund LA; Mann DW; Kilroy C; Haven ML; Nimz EL; Dutra JK; Li C; Minich ML; Kolosko NL; Petras C; Silvia AM; Seibel SB
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2076-80. PubMed ID: 16464588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiplatelet activity of carnosol is mediated by the inhibition of TXA2 receptor and cytosolic calcium mobilization.
    Lee JJ; Jin YR; Lim Y; Hong JT; Kim TJ; Chung JH; Yun YP
    Vascul Pharmacol; 2006 Sep; 45(3):148-53. PubMed ID: 16916624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis, and evaluation of 3,4-disubstituted pyrazole analogues as anti-tumor CDK inhibitors.
    Lin R; Chiu G; Yu Y; Connolly PJ; Li S; Lu Y; Adams M; Fuentes-Pesquera AR; Emanuel SL; Greenberger LM
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4557-61. PubMed ID: 17574416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.